Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
SRNE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
1.31%353.031.2%$871.11m
AMGNAmgen Inc.
-0.53%194.881.2%$564.77m
CELGCelgene Corporation
-0.54%85.231.2%$555.79m
GILDGilead Sciences, Inc.
-0.16%77.260.9%$499.41m
SRPTSarepta Therapeutics, Inc.
-1.97%136.6816.6%$376.94m
VRTXVertex Pharmaceuticals Incorporated
0.40%181.221.9%$331.68m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%364.752.6%$305.25m
ILMNIllumina, Inc.
-1.63%301.993.5%$267.19m
BLUEBluebird Bio, Inc.
-1.83%177.3015.7%$219.07m
NKTRNektar Therapeutics
0.00%47.795.6%$188.00m
ALXNAlexion Pharmaceuticals, Inc.
-0.95%134.582.0%$175.68m
FMIFoundation Medicine, Inc.
0.00%136.708.8%$168.36m
EXASExact Sciences Corporation
1.41%64.6625.4%$159.06m
BMRNBioMarin Pharmaceutical Inc.
-0.85%102.734.4%$138.72m
EXELExelixis, Inc.
-3.61%21.076.4%$137.74m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.